VSIR and clear cell renal carcinoma: Recent findings have demonstrated that VISTA is overexpressed in cholangiocarcinoma, glioblastoma multiforme, renal clear cell carcinoma, acute myeloid leukemia, lower-grade glioma, and pancreatic adenocarcinoma compared to healthy tissue.